Atlas Trials

Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation

Clinical trial NCT02417870 · TERMINATED

Trial details

NCT number
NCT02417870
Sponsor
Anil K. Chandraker, MD
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2015-09-01
Primary completion
2018-04-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.